Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Orbita raises $9 Million to Accelerate Conversational AI Solutions in Healthcare and Life Sciences

Orbita, the leading provider of conversational AI-powered voice and chatbot solutions for healthcare, announced today that it has secured $9M of venture funding as part of the company’s Series A financing round. Co-leading the round are Philips Health Technology Ventures, which manages a business-agnostic fund investing in future partners to drive Philips’ digital transformation, and HealthX Ventures, a digital healthcare-focused venture capital firm. Cultivation Capital and Newark Venture Partners also participated in the round.

Orbita’s award-winning voice and chatbot platform is used by leading healthcare, life sciences, and medical technology companies to improve patient care and clinical efficiency. Orbita’s enterprise-grade conversational platform supports AI-powered voice and chatbot applications accessible across web, mobile, SMS, smart speakers (Amazon Alexa and Google Assistant devices), and conventional phone.

“Philips views conversational AI through voice and chatbot as an important future enabler to drive patient experience and clinical efficiency, especially in light of the current COVID-19 pandemic,” said Rich Wilmot, Head of Philips Health Technology Ventures Global. “We aim to partner with and invest in promising digital health companies complementary to Philips strategic initiatives and Orbita has established itself as a leading innovator in the industry with products and solutions that are enterprise-ready, pressure tested, and highly relevant to the pressing needs of healthcare providers.”

Related Posts
1 of 40,034

In the past few months, Orbita has responded to an unprecedented number of requests related to COVID-19 from both existing and prospective customers across the globe. In March, Orbita announced a free COVID-19 chatbot designed to automate symptom screening and question-answering using content sourced from the U.S. Centers for Disease Control and Prevention (CDC). The company has since released additional capabilities to target the evolving demands of the pandemic, including automated health monitoring for patients, employees, and other at-risk populations. Through these and its other offerings, the company reports that its technology is now reaching millions of individuals worldwide.

Recommended AI News: ZebPay Expands Chainalysis Relationship in India

“The Orbita team quickly recognized how to apply their existing technology to deliver highly relevant solutions to the COVID-19 front-line response,” said Taha Jangda, Partner at HealthX Ventures. “In addition to their rapid turnaround with the COVID chatbot, they have made tremendous strides expanding into the life sciences market, where they are well-positioned to facilitate patient engagement and marketing in a post-COVID world. We are very pleased to continue supporting their progress.”

“Our mission has always been to transform lives through the power of voice and conversational AI,” said Bill Rogers, CEO at Orbita. “Thanks to our customers and partners, we’ve witnessed how virtual healthcare assistants based on our technology have improved both healthcare efficiency and quality. We’ve experienced this perhaps most significantly in recent weeks supporting the COVID-19 pandemic response. We’re very proud of the work we’ve done and are equally proud to receive the support of our new investors to expand our reach and impact.”

Comments are closed, but trackbacks and pingbacks are open.